R&D pipeline

Developing innovative products offering efficacy, safety and convenience

Estetrol pipeline

The many potential applications of Estetrol (E4) have been at the core of Mithra’s research for many years. Produced by the human fetus during pregnancy, this estrogen shows a specific mode of action compared to other estrogens.

Thanks to its unique profile, Estetrol could address unmet needs in various therapeutic areas such as contraception, menopause, neuroprotection in newborns or wound healing.

Pre-clinical
Phase 1
Phase 2
Phase 3
Filing
On the
market
Estelle® - Contraception
Donesta® - Menopause
Wound healing
Neuroprotection

Complex Therapeutics pipeline

Mithra has an extensive expertise in the development of complex and innovative products using medical polymer technology.

Throughout research and development programs, Mithra leverages its expertise to target improved, long-lasting delivery of trusted, established approaches to contraception, menopause and hormone-dependent cancers.

Pre-clinical
Phase 1
Phase 2
Phase 3
Filing
On the
market
Myring® - Contraception
Tibelia® - Menopause
Zoreline® - Hormonal cancers

Discover our E4 programs

Discover our Complex Therapeutics